• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Biotech

    Roivant’s CEO thinks China is a ‘red herring’

    FIERCE BIOTECH

    Pulmovant Completes Phase 2 Study Enrollment For Mosliciguat

    GLOBENEWSWIRE

    Roivant Reports Positive Phase 2 Data For Brepocitinib

    GLOBENEWSWIRE

    Roivant Highlights Progress and Outlook at Its 2025 Investor Day

    GLOBENEWSWIRE

    Roivant: Positive Batoclimab Myasthenia Gravis & CIDP Study Results

    GLOBENEWSWIRE

    Roivant to Host Investor Webcast on March 19 for Batoclimab Result

    GLOBENEWSWIRE

    Roivant`s Results from Namilumab Ph 2 Pulmonary Sarcoidosis Study

    GLOBENEWSWIRE

    Kinevant`s Results from Namilumab Ph 2 in Pulmonary Sarcoidosis

    GLOBENEWSWIRE

    Roivant Provides Update on Graves’ Disease Development Program

    GLOBENEWSWIRE

    Roivant Reports Positive Phase 2 Results for Batoclimab in Graves™ Disease

    GLOBENEWSWIRE

    Roivant Announces Positive IMVT-1402 Initial 600 mg MAD Results

    GLOBENEWSWIRE

    Roivant Announces Positive Initial IMVT-1402 Phase 1 SAD

    GLOBENEWSWIRE

    Telavant, a Roivant Company, Advances Inflammatory Bowel Disease Program with First Patient Dosed in Global Phase 2 Trial of Novel Anti-TL1A Antibody RVT-3101 in Crohn™s Disease

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.